Q2 2026 Holdings
Filed 2026-08-14 | 26 holdings | $11.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Therapeutics Corp(UTHR) | Common | 91307C102 | $1.5B | 2,777,777 | 13.5% |
| Ascendis Pharma(ASND) | ORDINARY SHARES | K08588103 | $1.4B | 5,111,111 | 12.2% |
| Krystal Biotech Inc(KRYS) | Common | 501147102 | $1.1B | 2,888,888 | 9.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $984.4M | 1,833,333 | 8.8% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $927.8M | 1,000,000 | 8.3% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $925.6M | 11,355,555 | 8.3% |
| Kymera Therapeutics Inc(KYMR) | Common | 501575104 | $857.1M | 7,474,747 | 7.7% |
| Revolution Medicines Inc(RVMD) | Common | 76155X100 | $430.2M | 2,297,000 | 3.9% |
| Cytokinetics Inc(CYTK) | Common | 23282W605 | $425.9M | 4,999,999 | 3.8% |
| Celcuity Inc(CELC) | Common | 15102K100 | $355.7M | 3,400,000 | 3.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $351.8M | 6,555,555 | 3.2% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $348.7M | 5,777,777 | 3.1% |
| Definium Therapeutics Inc(DFTX) | Common | 24477V105 | $338.2M | 7,188,888 | 3.0% |
| Uniqure NV(QURE) | Common | N90064101 | $309.9M | 6,727,777 | 2.8% |
| Vera Therapeutics Inc(VERA) | Common | 92337R101 | $245.6M | 5,723,888 | 2.2% |
| Taysha Gene Therapies Inc(TSHA) | Common | 877619106 | $162.7M | 23,888,888 | 1.5% |
| Ocular Therapeutix Inc(OCUL) | Common | 67576A100 | $123.1M | 12,540,000 | 1.1% |
| Damora Therapeutics Inc(GLTO) | Common | 36322Q206 | $98.4M | 3,783,000 | 0.9% |
| Hemab Therapeutics Hldgs Inc(COAG) | Common | 423494103 | $70.7M | 1,925,150 | 0.6% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $48.4M | 1,800,000 | 0.4% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $45.9M | 2,500,000 | 0.4% |
| Septerna Inc(SEPN) | Common | 81734D104 | $44.8M | 1,337,500 | 0.4% |
| Avalo Therapeutics(AVTX) | Common | 05338F306 | $43.1M | 2,333,333 | 0.4% |
| Faeth Therapeutics Inc(SNSE) | COMMON | 81728A207 | $36.1M | 1,444,039 | 0.3% |
| Whitehawk Therapeutics Inc(WHWK) | Common | 00032Q104 | $13.1M | 2,849,402 | 0.1% |
| Lexeo Therapeutics Inc(LXEO) | Common | 52886X107 | $6.9M | 1,489,189 | 0.1% |